These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32077338)

  • 1. Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.
    Montagna G; Morrow M
    Expert Rev Anticancer Ther; 2020 Mar; 20(3):159-166. PubMed ID: 32077338
    [No Abstract]   [Full Text] [Related]  

  • 2. Decisional conflict among breast cancer patients considering contralateral prophylactic mastectomy.
    Manne S; Smith B; Mitarotondo A; Frederick S; Toppmeyer D; Kirstein L
    Patient Educ Couns; 2019 May; 102(5):902-908. PubMed ID: 30553577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
    Jagsi R; Hawley ST; Griffith KA; Janz NK; Kurian AW; Ward KC; Hamilton AS; Morrow M; Katz SJ
    JAMA Surg; 2017 Mar; 152(3):274-282. PubMed ID: 28002555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).
    Tollow P; Williams VS; Harcourt D; Paraskeva N
    Psychooncology; 2019 Jun; 28(6):1328-1334. PubMed ID: 30963646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.
    Scheepens JCC; Veer LV'; Esserman L; Belkora J; Mukhtar RA
    Breast; 2021 Apr; 56():61-69. PubMed ID: 33621798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reframing the conversation about contralateral prophylactic mastectomy: Preparing women for postsurgical realities.
    Bloom DL; Chapman BM; Wheeler SB; McGuire KP; Lee CN; Weinfurt K; Rosenstein DL; Plichta JK; Jacobson Vann JC; Hwang ES
    Psychooncology; 2019 Feb; 28(2):394-400. PubMed ID: 30500102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefining Risk and Benefit: Understanding the Decision to Undergo Contralateral Prophylactic Mastectomy.
    Rendle KA; Halley MC; May SG; Frosch DL
    Qual Health Res; 2015 Sep; 25(9):1251-9. PubMed ID: 25371380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's preferences for contralateral prophylactic mastectomy: An investigation using protection motivation theory.
    Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P
    Patient Educ Couns; 2016 May; 99(5):814-22. PubMed ID: 27529090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
    Huang J; Chagpar A
    J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients.
    Hawley ST; Griffith KA; Hamilton AS; Ward KC; Morrow M; Janz NK; Katz SJ; Jagsi R
    Cancer; 2017 Dec; 123(23):4547-4555. PubMed ID: 28810062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy.
    Huang J; Chagpar A
    Am J Surg; 2019 Jul; 218(1):170-174. PubMed ID: 30554666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-Sure: a randomized pilot trial of an interactive web-based decision support aid versus usual care in average-risk breast cancer patients considering contralateral prophylactic mastectomy.
    Manne SL; Smith BL; Frederick S; Mitarotondo A; Kashy DA; Kirstein LJ
    Transl Behav Med; 2020 May; 10(2):355-363. PubMed ID: 30608607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
    Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
    Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contralateral prophylactic mastectomy for unilateral breast cancer in women at average risk: Systematic review of patient reported outcomes.
    Srethbhakdi A; Brennan ME; Hamid G; Flitcroft K
    Psychooncology; 2020 Jun; 29(6):960-973. PubMed ID: 32201988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practitioner Opinion on Contralateral Prophylactic Mastectomy: How Do We Steer a Patient-Driven Discussion?
    Schellenberg AE; Stypulkowski A; Cordeiro E; Holloway CMB; Eisen A; Scheer AS
    Ann Surg Oncol; 2019 Oct; 26(11):3489-3494. PubMed ID: 31187367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy.
    Ager B; Jansen J; Porter D; Phillips KA; Glassey R; ; Butow P
    Breast; 2018 Aug; 40():156-164. PubMed ID: 29857282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient opinions on contralateral prophylactic mastectomy: A patient-driven discussion in need of tuning?
    Brown ZM; Schellenberg AE; Cordeiro E; Holloway CMB; Scheer AS; Eisen A
    Can J Surg; 2022; 65(2):E250-E256. PubMed ID: 35365498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should the use of contralateral prophylactic mastectomy be increasing as it is?
    Wood WC
    Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of decision-making resources on satisfaction with decision to undergo contralateral prophylactic mastectomy (CPM).
    Huang J; Chagpar A
    Am J Surg; 2020 Jun; 219(6):1036-1038. PubMed ID: 31570198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
    Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
    Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.